Go Deep
TruAlt Bioenergy Limited
TruAlt Bioenergy Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,529 | 24.3 | 2.52 | 1.05 | 447.20 |
TruAlt Bioenergy Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 6,268,831,000.0 | 5,955,197,000.0 | 7,132,375,000.0 | 3,038,917,000.0 |
| Net Profit | 571,546,000.0 | 609,497,000.0 | 693,321,000.0 | 47,252,000.0 |
| EPS | 6.7 | 7.0 | 8.1 | 0.6 |
TruAlt Bioenergy Limited Revenue & Profit: Last 4 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 16,978,093,000.0 | 18,259,441,000.0 | 12,230,355,000.0 | 11,603,901,000.0 |
| Net Profit | 959,476,000.0 | 1,466,385,000.0 | 318,079,000.0 | 490,069,000.0 |
| EPS | 12.3 | — | — | — |
TruAlt Bioenergy Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 37,783,429,000.0 | 30,297,309,000.0 | 24,190,808,000.0 | 18,559,793,000.0 | — |
| Total Liabilities | 22,000,079,000.0 | 22,607,319,000.0 | 21,544,742,000.0 | 16,154,846,000.0 | — |
| Total Equity | 15,203,318,000.0 | 7,689,990,000.0 | 2,646,066,000.0 | 2,404,947,000.0 | — |
Owes vs Owns
TruAlt Bioenergy Limited owed ₹0.58 for every ₹1 it owned in Mar 2026, down from ₹0.87 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.58× | 0.75× | 0.89× | 0.87× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
TruAlt Bioenergy Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 2.5%Receivables 10.7%Inventory 14.0%Fixed assets (tangible) 56.8%Intangible assets 3.4%Long-term investments 0.6%Other assets 12.0%
How it's funded — Mar 2026
Short-term debt 17.4%Long-term debt 26.2%Payables 7.2%Other liabilities 7.5%Shareholders' equity 41.8%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 93.8 | 154.1 | 33.4 | 4.8 |
| Receivables | 406.1 | 339.3 | 298.2 | 86.5 |
| Inventory | 528.4 | 210.2 | 159.5 | 153.5 |
| Fixed assets (tangible) | 2,144.6 | 1,826.2 | 1,609.3 | 1,234.7 |
| Intangible assets | 128.0 | 139.1 | 150.3 | 152.9 |
| Long-term investments | 24.4 | 1.1 | 0.0 | 0.0 |
| Other assets | 453.0 | 359.7 | 168.3 | 223.5 |
| Liabilities & equity | ||||
| Short-term debt | 657.1 | 432.5 | 387.0 | 79.8 |
| Long-term debt | 988.7 | 1,117.2 | 979.6 | 783.5 |
| Payables | 272.1 | 485.7 | 153.6 | 308.7 |
| Other liabilities | 282.1 | 225.3 | 634.3 | 443.5 |
| Shareholders' equity | 1,578.3 | 769.0 | 264.6 | 240.5 |
| Net tangible assets | 1,392.4 | 629.9 | 114.3 | 87.6 |
TruAlt Bioenergy Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | -2,956,292,000.0 | 3,420,321,000.0 | 354,771,000.0 | 515,956,000.0 | — |
| Investing Activities | -4,134,513,000.0 | -2,553,270,000.0 | -3,836,662,000.0 | -4,738,219,000.0 | — |
| Financing Activities | 6,475,643,000.0 | 397,209,000.0 | 3,667,604,000.0 | 4,199,804,000.0 | — |